Back to BlackRock, Inc. BlackRock, Inc.

LTRNLTRN
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in LANTERN PHARMA INC

BlackRock, Inc. holds 22,350 shares of LTRN (LANTERN PHARMA INC), worth $93,199 as of 2026-Q2. The position was decreased (-50.6% shares).

Current Value

$93,199

Current Shares

22,350

Total Value Change

-$36,302

Total Shares Change

-18,246

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
22,350
-50.6%
$93,1990.0%$4.17
0
2026-Q1
Increased
45,267
+2.3%
$62,0160.0%$2.71
15
2025-Q4
Increased
44,253
+2.7%
$134,0870.0%$3.06
16
2025-Q3
Increased
43,090
+1.9%
$187,4430.0%$4.54
16
2025-Q2
Increased
42,275
+5.0%
$133,5890.0%$3.19
16
2025-Q1
Decreased
40,248
-0.9%
$142,4780.0%$3.55
0
2024-Q4
New
40,596
-
$129,5010.0%$3.27
34

Other major holders of LTRN: NewEdge Advisors, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used